DUBLIN--(BUSINESS WIRE)--The "Global Biopharmaceutical Contract Manufacturing Services - Procurement Market Intelligence Report" report has been added to ResearchAndMarkets.com's offering.
A biopharmaceutical contract manufacturing organization is an entity that provides services to the biopharmaceutical industry to develop and manufacture drugs in a comprehensive way. Contract manufacturing services refer to the production activities performed by a company for the label or brand of another company. Moreover, CMOs are the providers of such services to biotech and pharma companies, where designing and formulating of drugs are commonly based on consumers' specifications.
Also, biopharmaceutical companies avail contract manufacturing services due to the involvement of costly equipment and chemicals in mass drug production. Biopharma companies may sometimes be unable to afford such investments. Hence, they enter into a contract with third parties, such as CMOs, which possess suitable equipment and capacity to produce the expected drug formulations and final drugs.
The report provides actionable insights to improve source-to-contract cycle performance in the Global Biopharmaceutical Contract Manufacturing Services Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
- Teva Pharmaceuticals
- Boehringer Ingelheim
Key Topics Covered:
1: Category At A Glance
2: Scope Of The Report
3: Market Insights
4: Supply Market Insights
5: Pricing Insights
6: Procurement Insights
7: Top Five Suppliers
For more information about this report visit https://www.researchandmarkets.com/research/jffz67/global?w=4